Nichols AI - Search Results

1

Second generation model for prednisolone pharmacodynamics in the rat.

Nichols AI, Boudinot FD, Jusko WJ. Nichols AI, et al. J Pharmacokinet Biopharm. 1989 Apr;17(2):209-27. doi: 10.1007/BF01059029. J Pharmacokinet Biopharm. 1989. PMID: 2571711

2

Pharmacokinetics and pharmacodynamics of prednisolone in obese rats.

Nichols AI, D'Ambrosio R, Pyszczynski NA, Jusko WJ. Nichols AI, et al. J Pharmacol Exp Ther. 1989 Sep;250(3):963-70. J Pharmacol Exp Ther. 1989. PMID: 2778721

3

Receptor-mediated prednisolone pharmacodynamics in rats: model verification using a dose-sparing regimen.

Nichols AI, Jusko WJ. Nichols AI, et al. J Pharmacokinet Biopharm. 1990 Jun;18(3):189-208. doi: 10.1007/BF01062199. J Pharmacokinet Biopharm. 1990. PMID: 1974305

4

Extended least squares nonlinear regression: a possible solution to the "choice of weights" problem in analysis of individual pharmacokinetic data.

Peck CC, Beal SL, Sheiner LB, Nichols AI. Peck CC, et al. Among authors: nichols ai. J Pharmacokinet Biopharm. 1984 Oct;12(5):545-58. doi: 10.1007/BF01060132. J Pharmacokinet Biopharm. 1984. PMID: 6520748

5

The problem of choosing weights in nonlinear regression analysis of pharmacokinetic data.

Peck CC, Sheiner LB, Nichols AI. Peck CC, et al. Among authors: nichols ai. Drug Metab Rev. 1984;15(1-2):133-48. doi: 10.3109/03602538409015060. Drug Metab Rev. 1984. PMID: 6745079 No abstract available.

6

Open-label, 2-period sequential drug interaction study to evaluate the effect of a 100-mg dose of desvenlafaxine on the pharmacokinetics of tamoxifen when coadministered in healthy postmenopausal female subjects.

Nichols AI, Lubaczewski S, Liang Y, Matschke K, Braley G, Ramey T. Nichols AI, et al. Int J Clin Pharmacol Ther. 2014 Oct;52(10):830-41. doi: 10.5414/CP201958. Int J Clin Pharmacol Ther. 2014. PMID: 25138680 Clinical Trial.

7

An open-label, single-dose, parallel-group study of the effects of chronic hepatic impairment on the safety and pharmacokinetics of desvenlafaxine.

Baird-Bellaire S, Behrle JA, Parker VD, Patat A, Paul J, Nichols AI. Baird-Bellaire S, et al. Among authors: nichols ai. Clin Ther. 2013 Jun;35(6):782-94. doi: 10.1016/j.clinthera.2013.03.013. Epub 2013 Apr 25. Clin Ther. 2013. PMID: 23623756 Clinical Trial.

8

Effects of desvenlafaxine on the pharmacokinetics of desipramine in healthy adults.

Nichols AI, Abell M, Chen Y, Behrle JA, Frick G, Paul J. Nichols AI, et al. Int Clin Psychopharmacol. 2013 Mar;28(2):99-105. doi: 10.1097/YIC.0b013e32835c1f49. Int Clin Psychopharmacol. 2013. PMID: 23221858 Clinical Trial.

9

Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers.

Preskorn S, Patroneva A, Silman H, Jiang Q, Isler JA, Burczynski ME, Ahmed S, Paul J, Nichols AI. Preskorn S, et al. Among authors: nichols ai. J Clin Psychopharmacol. 2009 Feb;29(1):39-43. doi: 10.1097/JCP.0b013e318192e4c1. J Clin Psychopharmacol. 2009. PMID: 19142106 Clinical Trial.

10

An assessment of drug-drug interactions: the effect of desvenlafaxine and duloxetine on the pharmacokinetics of the CYP2D6 probe desipramine in healthy subjects.

Patroneva A, Connolly SM, Fatato P, Pedersen R, Jiang Q, Paul J, Guico-Pabia C, Isler JA, Burczynski ME, Nichols AI. Patroneva A, et al. Among authors: nichols ai. Drug Metab Dispos. 2008 Dec;36(12):2484-91. doi: 10.1124/dmd.108.021527. Epub 2008 Sep 22. Drug Metab Dispos. 2008. PMID: 18809731 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results